Trial Profile
Study of Ospemifene in menopausal patients with vulvovaginal atrophy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Dec 2018
Price :
$35
*
At a glance
- Drugs Ospemifene (Primary)
- Indications Atrophic vaginitis
- Focus Therapeutic Use
- 07 Dec 2018 New trial record